333 related articles for article (PubMed ID: 28603525)
1. Modulating Both Tumor Cell Death and Innate Immunity Is Essential for Improving Radiation Therapy Effectiveness.
Wu Q; Allouch A; Martins I; Brenner C; Modjtahedi N; Deutsch E; Perfettini JL
Front Immunol; 2017; 8():613. PubMed ID: 28603525
[TBL] [Abstract][Full Text] [Related]
2. Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors.
Derer A; Frey B; Fietkau R; Gaipl US
Cancer Immunol Immunother; 2016 Jul; 65(7):779-86. PubMed ID: 26590829
[TBL] [Abstract][Full Text] [Related]
3. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
Esposito A; Criscitiello C; Curigliano G
Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
[TBL] [Abstract][Full Text] [Related]
4. Combination of radiotherapy and immune checkpoint inhibitors.
Pilones KA; Vanpouille-Box C; Demaria S
Semin Radiat Oncol; 2015 Jan; 25(1):28-33. PubMed ID: 25481263
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy.
Kim BM; Hong Y; Lee S; Liu P; Lim JH; Lee YH; Lee TH; Chang KT; Hong Y
Int J Mol Sci; 2015 Nov; 16(11):26880-913. PubMed ID: 26569225
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulation of NK Cells by Ionizing Radiation.
Chen J; Liu X; Zeng Z; Li J; Luo Y; Sun W; Gong Y; Zhang J; Wu Q; Xie C
Front Oncol; 2020; 10():874. PubMed ID: 32612950
[TBL] [Abstract][Full Text] [Related]
7. Barriers to Radiation-Induced
Wennerberg E; Lhuillier C; Vanpouille-Box C; Pilones KA; García-Martínez E; Rudqvist NP; Formenti SC; Demaria S
Front Immunol; 2017; 8():229. PubMed ID: 28348554
[TBL] [Abstract][Full Text] [Related]
8. Ionizing radiation results in a mixture of cellular outcomes including mitotic catastrophe, senescence, methuosis, and iron-dependent cell death.
Adjemian S; Oltean T; Martens S; Wiernicki B; Goossens V; Vanden Berghe T; Cappe B; Ladik M; Riquet FB; Heyndrickx L; Bridelance J; Vuylsteke M; Vandecasteele K; Vandenabeele P
Cell Death Dis; 2020 Nov; 11(11):1003. PubMed ID: 33230108
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases.
Frey B; Rückert M; Deloch L; Rühle PF; Derer A; Fietkau R; Gaipl US
Immunol Rev; 2017 Nov; 280(1):231-248. PubMed ID: 29027224
[TBL] [Abstract][Full Text] [Related]
10. The convergence of radiation and immunogenic cell death signaling pathways.
Golden EB; Pellicciotta I; Demaria S; Barcellos-Hoff MH; Formenti SC
Front Oncol; 2012; 2():88. PubMed ID: 22891162
[TBL] [Abstract][Full Text] [Related]
11. CTLA-4 blockade enhances antitumor immunity of intratumoral injection of immature dendritic cells into irradiated tumor in a mouse colon cancer model.
Son CH; Bae JH; Shin DY; Lee HR; Choi YJ; Jo WS; Ho Jung M; Kang CD; Yang K; Park YS
J Immunother; 2014 Jan; 37(1):1-7. PubMed ID: 24316550
[TBL] [Abstract][Full Text] [Related]
12. Combined treatment of human colorectal tumor cell lines with chemotherapeutic agents and ionizing irradiation can in vitro induce tumor cell death forms with immunogenic potential.
Frey B; Stache C; Rubner Y; Werthmöller N; Schulz K; Sieber R; Semrau S; Rödel F; Fietkau R; Gaipl US
J Immunotoxicol; 2012; 9(3):301-13. PubMed ID: 22800185
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated Irradiation Has Immune Stimulatory Potential and Induces a Timely Restricted Infiltration of Immune Cells in Colon Cancer Tumors.
Frey B; Rückert M; Weber J; Mayr X; Derer A; Lotter M; Bert C; Rödel F; Fietkau R; Gaipl US
Front Immunol; 2017; 8():231. PubMed ID: 28337197
[TBL] [Abstract][Full Text] [Related]
14. Dying cell clearance and its impact on the outcome of tumor radiotherapy.
Lauber K; Ernst A; Orth M; Herrmann M; Belka C
Front Oncol; 2012; 2():116. PubMed ID: 22973558
[TBL] [Abstract][Full Text] [Related]
15. Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications.
Derer A; Deloch L; Rubner Y; Fietkau R; Frey B; Gaipl US
Front Immunol; 2015; 6():505. PubMed ID: 26500646
[TBL] [Abstract][Full Text] [Related]
16. Harnessing the Immunological Effects of Radiation to Improve Immunotherapies in Cancer.
Hannon G; Lesch ML; Gerber SA
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108522
[TBL] [Abstract][Full Text] [Related]
17. Innate Immune System in the Context of Radiation Therapy for Cancer.
Boopathi E; Den RB; Thangavel C
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568788
[TBL] [Abstract][Full Text] [Related]
18. Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy.
Sharabi AB; Lim M; DeWeese TL; Drake CG
Lancet Oncol; 2015 Oct; 16(13):e498-509. PubMed ID: 26433823
[TBL] [Abstract][Full Text] [Related]
19. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells.
Roninson IB; Broude EV; Chang BD
Drug Resist Updat; 2001 Oct; 4(5):303-13. PubMed ID: 11991684
[TBL] [Abstract][Full Text] [Related]
20. Immunogenic cell death modalities and their impact on cancer treatment.
Kepp O; Tesniere A; Schlemmer F; Michaud M; Senovilla L; Zitvogel L; Kroemer G
Apoptosis; 2009 Apr; 14(4):364-75. PubMed ID: 19145485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
